2026 Bruce L. Innis: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	82	1493	1360	127	121	249	27348
Medicine	82	16017	15069	1471	1405	249	27348

Overview

Bruce L. Innis is affiliated with GlaxoSmithKline in the United Kingdom and has contributed extensively to the field of medical research, with a particular focus on respiratory viral infections.

The scientist's primary field of study is Medicine, with specialized work in several subfields including Epidemiology, Infectious Diseases, Microbiology, Immunology, and Animal Science and Zoology. This range reflects a multidisciplinary approach to understanding infectious diseases and their impacts.

Key research topics pursued by Bruce L. Innis cover a broad spectrum of viral and bacterial infections, particularly those affecting the respiratory system. These topics include:

Respiratory viral infections research
Influenza Virus Research Studies
SARS-CoV-2 and COVID-19 Research
Virology and Viral Diseases
Pneumonia and Respiratory Infections
Bacterial Infections and Vaccines
Animal Virus Infections Studies

Bruce L. Innis has been published frequently in various academic venues. The most common publication outlets are as follows:

Vaccine
Value in Health
bioRxiv (Cold Spring Harbor Laboratory)
Vaccines
The Lancet Infectious Diseases

Their research has involved collaboration with several coauthors, with numerous joint publications. Frequent collaborators include:

Florian Krammer
Peter Palese
Adolfo García-Sastre
Weina Sun
Rama Raghunandan

Recent publications by Bruce L. Innis illustrate involvement in vaccine research and viral immunology. Notable papers include:

"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial" (2020), published in Nature Medicine
"A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses" (2021), published in Nature Communications
"Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting" (2020), published in Vaccine
"A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine" (2020), published in Vaccines
"A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future" (2021), published in Vaccine

Best Publications

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris

2367
Citations
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Guillermo M. Ruiz-Palacios;Irene Pérez-Schael;F. Raúl Velázquez;Hector Abate

2352
Citations
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity

David W. Vaughn;Sharone Green;Siripen Kalayanarooj;Bruce L. Innis

2058
Citations
An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

B. L. Innis;A. Nisalak;S. Nimmannitya;S. Kusalerdchariya

1001
Citations
Early Clinical and Laboratory Indicators of Acute Dengue Illness

S. Kalayanarooj;D. W. Vaughn;S. Nimmannitya;S. Green

931
Citations
Safety and Efficacy of a Recombinant Hepatitis E Vaccine

Mrigendra Prasad Shrestha;Robert McNair Scott;Durga Man Joshi;Mammen P. Mammen

686
Citations
Protection against hepatitis A by an inactivated vaccine.

Innis Bl;Snitbhan R;Kunasol P;Laorakpongse T

593
Citations
Protection against Japanese Encephalitis by Inactivated Vaccines

C H Hoke;A Nisalak;N Sangawhipa;S Jatanasen

559
Citations
Dengue in the early febrile phase : Viremia and antibody responses

David W. Vaughn;Sharone Green;Siripen Kalayanarooj;Bruce L. Innis

550
Citations
SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999

Ananda Nisalak;Timothy P. Endy;Suchitra Nimmannitya;Siripen Kalayanarooj

544
Citations
Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

Sharone Green;David W. Vaughn;Siripen Kalayanarooj;Suchitra Nimmannitya

480
Citations
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.

Ichiro Kurane;Bruce L. Innis;Suchitra Nimmannitya;Ananda Nisalak

458
Citations
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized, controlled trial

Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron G. Ferris

387
Citations
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.

Raffael Nachbagauer;Jodi Feser;Abdollah Naficy;David I. Bernstein;David I. Bernstein

339
Citations
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

N. Kanesa-thasan;W. Sun;G. Kim-Ahn;S. Van Albert

318
Citations
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais

H. A. F. Stephens;H. A. F. Stephens;R. Klaythong;M. Sirikong;D. W. Vaughn

313
Citations
Impact of Dengue Virus Infection on Feeding Behavior of Aedes aegypti

Kenneth B. Platt;Kenneth J. Linthicum;Khin S. A. Myint;Bruce L. Innis

287
Citations
Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal

Edward T. Clayson;Bruce L. Innis;Khin Saw Aye Myint;Sumitda Narupiti

259
Citations
Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E

Edward T. Clayson;Khin Saw Aye Myint;Rapin Snitbhan;David W. Vaughn

247
Citations
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

Robert Edelman;Steven S. Wasserman;Sacared A. Bodison;Robert J. Putnak

246
Citations
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

J. Robert Putnak;Beth-Ann Coller;Gerald Voss;David W. Vaughn

223
Citations

Frequent Co-Authors

David W. Vaughn Bill & Melinda Gates Foundation

Charles H. Hoke Walter Reed Army Institute of Research

Kenneth H. Eckels Walter Reed Army Institute of Research

Ananda Nisalak United States Department of the Army

Gary Dubin GlaxoSmithKline (United Kingdom)

Francis A. Ennis University of Massachusetts Chan Medical School

Robert V. Gibbons United States Department of the Army

Sharone Green University of Massachusetts Chan Medical School

Jose L. Sanchez Defense Health Agency

Richard G. Jarman Walter Reed Army Institute of Research

External Links

Personal website of Bruce L. Innis

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees can open diverse career opportunities in healthcare and research. Many professionals transition into nursing roles, which complement immunology expertise. Accelerated educational routes are particularly popular for individuals looking to advance quickly.

Non-nurses can explore online accelerated nursing programs for non nurses, designed to fast-track their entry into the nursing field. These programs provide comprehensive training suitable for those new to healthcare but eager to make an impact.

Similarly, accelerated BSN programs for non nurses offer a focused path for aspiring nurses, especially those holding degrees in other disciplines. With a shorter timeframe than traditional routes, these programs emphasize practical skills and immunology-related knowledge critical for patient care.

For licensed practical nurses looking to advance, identifying lpn schools easy to get into is a step toward building foundational healthcare expertise. Additionally, experienced nursing professionals may consider accelerated NP programs to become nurse practitioners, expanding their scope in clinical immunology and patient management.